• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症患者皮质病变与认知障碍的相关性。

Correlation between cortical lesions and cognitive impairment in multiple sclerosis.

机构信息

Neurosciences Unit, Department of Medicine and Surgery (DMEC), University of Parma, Parma, Italy.

Neuroradiology Unit, Department of Diagnostic, Parma University Hospital, Parma, Italy.

出版信息

Brain Behav. 2018 Jun;8(6):e00955. doi: 10.1002/brb3.955. Epub 2018 Apr 21.

DOI:10.1002/brb3.955
PMID:29974667
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5991593/
Abstract

OBJECTIVES

Gray matter (GM) damage is well known as a fundamental aspect of multiple sclerosis (MS). Above all, cortical lesions (CLs) burden, detectable at MRI with double inversion recovery (DIR) sequences, has been demonstrated to correlate with cognitive impairment (CI). The aim of this study was to investigate the role of CLs number in predicting CI in a cohort of patients with MS in a clinical practice setting.

MATERIALS AND METHODS

Thirty consecutive patients with MS presenting CLs (CL+) at high-field (3.0 T) MRI 3D-DIR sequences and an even group of MS patients without CLs (CL-) as a control, were investigated with the Rao Brief Repeatable Battery of Neuropsychological Tests (BRB), Version A. Total and lobar CLs number were computed in CL+ patients.

RESULTS

Among the sixty patients with MS enrolled, forty-seven (78.3%) had a relapsing-remitting course, while thirteen (21.7%) a progressive one, eleven secondary progressive, and two primary progressive. Compared to CL-, CL+ patients had a greater proportion of progressive forms (p = .03). The most affected region was the frontal lobe (73.3% of patients), followed by temporal and parietal ones (both 60.0%). Multivariate (logistic regression) analysis revealed a significant correlation between total CLs number and the presence of mild cognitive impairment defined as pathologic score in at least one BRB test (p = .04); it was also correlated with deficit at PASAT 3 (p = .05) and Stroop Test (p = .02).

CONCLUSIONS

We confirmed CLs number, evaluated with a technique quite commonly available in clinical practice, as a predictive factor of CI in patients with MS, in order to improve the diagnosis and management of CI and monitor potential neuroprotective effects of therapies.

摘要

目的

众所周知,灰质(GM)损伤是多发性硬化症(MS)的一个基本特征。尤其是,皮质病变(CLs)负担,可通过磁共振成像(MRI)的双反转恢复(DIR)序列检测到,已被证明与认知障碍(CI)相关。本研究旨在探讨在临床实践环境中,MS 患者 CL 数量在预测 CI 中的作用。

材料和方法

对 30 例在高场(3.0T)MRI 3D-DIR 序列上显示 CL(CL+)的连续 MS 患者和一组作为对照的无 CL(CL-)MS 患者进行了研究,采用 Rao 简明重复神经心理测试组(BRB),A 版。在 CL+患者中计算了总 CL 和叶 CL 的数量。

结果

在纳入的 60 例 MS 患者中,47 例(78.3%)为复发缓解型,13 例(21.7%)为进展型,其中 11 例为继发进展型,2 例为原发进展型。与 CL-患者相比,CL+患者进展型的比例更高(p=0.03)。受影响最严重的区域是额叶(73.3%的患者),其次是颞叶和顶叶(均为 60.0%)。多变量(逻辑回归)分析显示,总 CL 数量与存在轻度认知障碍(BRB 测试中至少有一项病理评分)显著相关(p=0.04);它还与 PASAT3 缺陷(p=0.05)和 Stroop 测试(p=0.02)相关。

结论

我们证实了 CL 数量(通过一种在临床实践中相当常用的技术评估)是 MS 患者 CI 的预测因素,以提高 CI 的诊断和管理,并监测潜在的神经保护治疗效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bdc/5991593/1f46ed9e0860/BRB3-8-e00955-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bdc/5991593/1f46ed9e0860/BRB3-8-e00955-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bdc/5991593/1f46ed9e0860/BRB3-8-e00955-g001.jpg

相似文献

1
Correlation between cortical lesions and cognitive impairment in multiple sclerosis.多发性硬化症患者皮质病变与认知障碍的相关性。
Brain Behav. 2018 Jun;8(6):e00955. doi: 10.1002/brb3.955. Epub 2018 Apr 21.
2
Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis.复发缓解型多发性硬化中与认知障碍相关的皮质病变和萎缩
Arch Neurol. 2009 Sep;66(9):1144-50. doi: 10.1001/archneurol.2009.174.
3
Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.皮质和白质病变对多发性硬化认知障碍的影响。
Mult Scler. 2013 Sep;19(10):1290-6. doi: 10.1177/1352458513475490. Epub 2013 Mar 4.
4
Clinical significance of cortical lesions in patients with multiple sclerosis: A neuropsychological and neuroimaging study.多发性硬化症患者皮质病变的临床意义:一项神经心理学和神经影像学研究。
Brain Behav. 2018 Feb 14;8(3):e00934. doi: 10.1002/brb3.934. eCollection 2018 Mar.
5
DT MRI microstructural cortical lesion damage does not explain cognitive impairment in MS.DT MRI 显示皮质微结构损伤并不会解释 MS 患者的认知障碍。
Mult Scler. 2017 Dec;23(14):1918-1928. doi: 10.1177/1352458516689147. Epub 2017 Jan 18.
6
Contribution of cortical lesions to cognitive impairment in Japanese patients with multiple sclerosis.皮质病变对日本多发性硬化症患者认知障碍的影响。
Sci Rep. 2020 Mar 23;10(1):5228. doi: 10.1038/s41598-020-61012-3.
7
Cortical lesions at diagnosis predict long-term cognitive impairment in multiple sclerosis: A 20-year study.诊断时的皮质病变可预测多发性硬化症的长期认知障碍:一项20年的研究。
Eur J Neurol. 2023 May;30(5):1378-1388. doi: 10.1111/ene.15697. Epub 2023 Feb 19.
8
A clinically feasible 7-Tesla protocol for the identification of cortical lesions in Multiple Sclerosis.一种在临床上可行的 7 特斯拉协议,用于识别多发性硬化症中的皮质病变。
Eur Radiol. 2020 Aug;30(8):4586-4594. doi: 10.1007/s00330-020-06803-y. Epub 2020 Mar 24.
9
Estriol-mediated neuroprotection in multiple sclerosis localized by voxel-based morphometry.基于体素形态计量学的雌三醇介导的多发性硬化症神经保护作用。
Brain Behav. 2018 Sep;8(9):e01086. doi: 10.1002/brb3.1086. Epub 2018 Aug 24.
10
Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.多发性硬化症认知能力下降的预测:一项 5 年随访研究。
Brain. 2018 Sep 1;141(9):2605-2618. doi: 10.1093/brain/awy202.

引用本文的文献

1
Improved myelin water imaging using B correction and data-driven global feature extraction: Application on people with MS.使用B₀校正和数据驱动的全局特征提取改进髓鞘水成像:在多发性硬化症患者中的应用。
Imaging Neurosci (Camb). 2024 Jul 31;2. doi: 10.1162/imag_a_00254. eCollection 2024.
2
Inflammatory mechanisms underlying cortical injury in progressive multiple sclerosis.进展性多发性硬化症中皮质损伤的炎症机制
Neuroimmunol Neuroinflamm. 2021;8:111-133. doi: 10.20517/2347-8659.2020.35. Epub 2021 Jun 20.
3
Dementia in People With Multiple Sclerosis: A Systematic Review and Meta-Analysis.

本文引用的文献

1
Regional Distribution and Evolution of Gray Matter Damage in Different Populations of Multiple Sclerosis Patients.多发性硬化症患者不同群体中灰质损伤的区域分布与演变
PLoS One. 2015 Aug 12;10(8):e0135428. doi: 10.1371/journal.pone.0135428. eCollection 2015.
2
Multi-parametric structural magnetic resonance imaging in relation to cognitive dysfunction in long-standing multiple sclerosis.多参数结构磁共振成像与长期多发性硬化认知功能障碍的关系。
Mult Scler. 2016 Apr;22(5):608-19. doi: 10.1177/1352458515596598. Epub 2015 Jul 24.
3
Subclinical MRI disease activity influences cognitive performance in MS patients.
多发性硬化症患者的痴呆症:系统评价与荟萃分析
Brain Behav. 2025 Jun;15(6):e70588. doi: 10.1002/brb3.70588.
4
Proteomic analysis reveals candidate molecules to mediate cortical pathology and identify possible biomarkers in an animal model of multiple sclerosis.蛋白质组学分析揭示了介导皮质病理学的候选分子,并在多发性硬化症动物模型中鉴定了可能的生物标志物。
Front Immunol. 2025 Feb 13;16:1505459. doi: 10.3389/fimmu.2025.1505459. eCollection 2025.
5
Prevalence of cognitive impairment (CI) in patients with multiple sclerosis (MS): A systematic review and meta-analysis.多发性硬化症(MS)患者认知障碍(CI)的患病率:一项系统评价和荟萃分析。
Caspian J Intern Med. 2024 Summer;15(3):392-413. doi: 10.22088/cjim.15.3.392.
6
Lifestyle management and brain MRI metrics in female Australian adults living with multiple sclerosis: a feasibility and acceptability study.澳大利亚成年多发性硬化症女性患者的生活方式管理与脑部磁共振成像指标:一项可行性与可接受性研究
Pilot Feasibility Stud. 2024 May 2;10(1):71. doi: 10.1186/s40814-024-01495-3.
7
The cognitive relevance of non-lesional damage to cortical networks in people with multiple sclerosis.多发性硬化症患者皮质网络非病灶性损伤的认知相关性。
J Neurol. 2024 Jun;271(6):3203-3214. doi: 10.1007/s00415-024-12240-4. Epub 2024 Mar 5.
8
Isolated cognitive impairment in people with multiple sclerosis: frequency, MRI patterns and its development over time.多发性硬化症患者的孤立性认知障碍:发生率、MRI表现及其随时间的发展
J Neurol. 2024 May;271(5):2159-2168. doi: 10.1007/s00415-024-12185-8. Epub 2024 Jan 30.
9
Emerging imaging and liquid biomarkers in multiple sclerosis.多发性硬化症中的新兴影像和液体生物标志物。
Eur J Immunol. 2023 Aug;53(8):e2250228. doi: 10.1002/eji.202250228. Epub 2023 May 28.
10
Recent Progress in the Identification of Early Transition Biomarkers from Relapsing-Remitting to Progressive Multiple Sclerosis.从复发缓解型到进展型多发性硬化症早期转变生物标志物的最新研究进展。
Int J Mol Sci. 2023 Feb 22;24(5):4375. doi: 10.3390/ijms24054375.
亚临床磁共振成像疾病活动会影响多发性硬化症患者的认知表现。
Mult Scler Relat Disord. 2015 Mar;4(2):137-43. doi: 10.1016/j.msard.2015.01.006. Epub 2015 Jan 24.
4
Contribution of cortical lesion subtypes at 7T MRI to physical and cognitive performance in MS.7T MRI 下皮质病变亚型对 MS 患者躯体和认知功能的影响。
Neurology. 2013 Aug 13;81(7):641-9. doi: 10.1212/WNL.0b013e3182a08ce8. Epub 2013 Jul 17.
5
Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.皮质和白质病变对多发性硬化认知障碍的影响。
Mult Scler. 2013 Sep;19(10):1290-6. doi: 10.1177/1352458513475490. Epub 2013 Mar 4.
6
Measurement and clinical effect of grey matter pathology in multiple sclerosis.多发性硬化症中脑灰质病变的测量和临床效果。
Lancet Neurol. 2012 Dec;11(12):1082-92. doi: 10.1016/S1474-4422(12)70230-2.
7
Grey matter lesions in MS: from histology to clinical implications.多发性硬化症中的灰质病变:从组织病理学到临床意义。
Prion. 2013 Jan-Feb;7(1):20-7. doi: 10.4161/pri.22580. Epub 2012 Oct 23.
8
Cognitive impairment in multiple sclerosis.多发性硬化症中的认知障碍。
Curr Neurol Neurosci Rep. 2012 Oct;12(5):618-27. doi: 10.1007/s11910-012-0294-3.
9
Exploration of the relationships between regional grey matter atrophy and cognition in multiple sclerosis.多发性硬化症中区域灰质萎缩与认知之间关系的探索。
Brain Imaging Behav. 2014 Sep;8(3):378-86. doi: 10.1007/s11682-012-9170-7.
10
Cognitive impairment in multiple sclerosis.多发性硬化中的认知障碍。
Minerva Med. 2012 Apr;103(2):73-96.